department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Tufts Medical Center · pharmadog

PUBLIC COMPANY

Tufts Medical Center

updated 2mo ago

community read0 votes

pipeline

0

marketed

0

phase 3

0

catalysts ytd

2

approvals ytd

0

recalls ytd

0

Pipeline(0)

no pipeline products on record

Upcoming

no upcoming catalysts on record

Recent(90d)

phase 2 completion (1)

view all catalysts →

🐶 Hiring Signal

No open roles indexed yet — view Tufts Medical Center jobs →

News

no news has mentioned this company yet

identifiers

source

globaldata

mentioned in

0news items

entity-linker matched

phase 2 completion

Tufts Medical Center — phytonadione (Phase II Trial Completion)

Active trials

—Pulmonary Embolism and Right-to-Left Shuntsrecruitingn=256
phase3Vitamin D and Type 2 Diabetes - Treat-To-Targetnot yet recruitingn=100
—Neurosensory Abnormalities in SymptomAtic Ocular Surface Patients (NASA)suspendedn=1,000
N/AQST for Corneal Nerve Functionsuspendedn=108
phase1Fractionated Docetaxel and Radium 223 in Metastatic Castration-Resistant Prostate Cancercompletedn=43
phase4Letermovir Use in Heart Transplant Recipientscompletedn=32
—Ventilatory and Perfusion Abnormalities in Individuals With Post-Acute Sequelae of SARS-CoV-2 Infectionrecruitingn=40
—Cardiogenic Shock Working Group Registryrecruitingn=5,000

more trials →

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

🐶 often sniffed alongside

top 5

tagOrthopedics1 co-mentions · 1 sources
tagVaccines1 co-mentions · 1 sources
tagIBD (Crohn's + UC)1 co-mentions · 1 sources
drugPHYTONADIONE1 co-mentions · 1 sources
drugVITAMIN K11 co-mentions · 1 sources